365 related articles for article (PubMed ID: 32570885)
1. Niosomal Drug Delivery Systems for Ocular Disease-Recent Advances and Future Prospects.
Durak S; Esmaeili Rad M; Alp Yetisgin A; Eda Sutova H; Kutlu O; Cetinel S; Zarrabi A
Nanomaterials (Basel); 2020 Jun; 10(6):. PubMed ID: 32570885
[TBL] [Abstract][Full Text] [Related]
2. Current advances in niosomes applications for drug delivery and cancer treatment.
Moammeri A; Chegeni MM; Sahrayi H; Ghafelehbashi R; Memarzadeh F; Mansouri A; Akbarzadeh I; Abtahi MS; Hejabi F; Ren Q
Mater Today Bio; 2023 Dec; 23():100837. PubMed ID: 37953758
[TBL] [Abstract][Full Text] [Related]
3. Applications of Nanotechnology-mediated Herbal Nanosystems for Ophthalmic Drug.
Shree D; Patra CN; Sahoo BM
Pharm Nanotechnol; 2024; 12(3):229-250. PubMed ID: 37587812
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in non-ionic surfactant vesicles (niosomes): Fabrication, characterization, pharmaceutical and cosmetic applications.
Chen S; Hanning S; Falconer J; Locke M; Wen J
Eur J Pharm Biopharm; 2019 Nov; 144():18-39. PubMed ID: 31446046
[TBL] [Abstract][Full Text] [Related]
5. Niosomes: a novel targeted drug delivery system for cancer.
Moghtaderi M; Sedaghatnia K; Bourbour M; Fatemizadeh M; Salehi Moghaddam Z; Hejabi F; Heidari F; Quazi S; Farasati Far B
Med Oncol; 2022 Sep; 39(12):240. PubMed ID: 36175809
[TBL] [Abstract][Full Text] [Related]
6. Current Advances in Specialised Niosomal Drug Delivery: Manufacture, Characterization and Drug Delivery Applications.
Witika BA; Bassey KE; Demana PH; Siwe-Noundou X; Poka MS
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077066
[TBL] [Abstract][Full Text] [Related]
7. Fostering the unleashing potential of nanocarriers-mediated delivery of ocular therapeutics.
Datta D; Priyanka Bandi S; Colaco V; Dhas N; Siva Reddy DV; Vora LK
Int J Pharm; 2024 Jun; 658():124192. PubMed ID: 38703931
[TBL] [Abstract][Full Text] [Related]
8. Nano-niosomes as nanoscale drug delivery systems: an illustrated review.
Moghassemi S; Hadjizadeh A
J Control Release; 2014 Jul; 185():22-36. PubMed ID: 24747765
[TBL] [Abstract][Full Text] [Related]
9. Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases.
Onugwu AL; Nwagwu CS; Onugwu OS; Echezona AC; Agbo CP; Ihim SA; Emeh P; Nnamani PO; Attama AA; Khutoryanskiy VV
J Control Release; 2023 Feb; 354():465-488. PubMed ID: 36642250
[TBL] [Abstract][Full Text] [Related]
10. Ten Years of Knowledge of Nano-Carrier Based Drug Delivery Systems in Ophthalmology: Current Evidence, Challenges, and Future Prospective.
Zhang J; Jiao J; Niu M; Gao X; Zhang G; Yu H; Yang X; Liu L
Int J Nanomedicine; 2021; 16():6497-6530. PubMed ID: 34588777
[TBL] [Abstract][Full Text] [Related]
11. A Compendium of Bioavailability Enhancement
Sharma S; Kumari N; Garg D; Chauhan S
Pharm Nanotechnol; 2023; 11(4):324-338. PubMed ID: 36892113
[TBL] [Abstract][Full Text] [Related]
12. Nanocarriers Based Ocular Therapeutics: Updates, Challenges and Future Prospectives.
Kaushal U; Kaur M; Nagpal M; Bhuyan M; Gounder KP
Curr Drug Res Rev; 2023; 15(1):15-28. PubMed ID: 36100986
[TBL] [Abstract][Full Text] [Related]
13. Niosomes from 80s to present: the state of the art.
Marianecci C; Di Marzio L; Rinaldi F; Celia C; Paolino D; Alhaique F; Esposito S; Carafa M
Adv Colloid Interface Sci; 2014 Mar; 205():187-206. PubMed ID: 24369107
[TBL] [Abstract][Full Text] [Related]
14. Nanocarriers in ocular drug delivery: an update review.
Wadhwa S; Paliwal R; Paliwal SR; Vyas SP
Curr Pharm Des; 2009; 15(23):2724-50. PubMed ID: 19689343
[TBL] [Abstract][Full Text] [Related]
15. Niosome-loaded antifungal drugs as an effective nanocarrier system: A mini review.
Osanloo M; Assadpour S; Mehravaran A; Abastabar M; Akhtari J
Curr Med Mycol; 2018 Dec; 4(4):31-36. PubMed ID: 30815615
[TBL] [Abstract][Full Text] [Related]
16. A Mini-review on New Developments in Nanocarriers and Polymers for Ophthalmic Drug Delivery Strategies.
Sharma Y; Patel P; Kurmi BD
Curr Drug Deliv; 2024; 21(4):488-508. PubMed ID: 37143264
[TBL] [Abstract][Full Text] [Related]
17. Factors Affecting the Penetration of Niosome into the Skin, Their Laboratory Measurements and Dependency to the Niosome Composition: A Review.
Kheilnezhad B; Hadjizadeh A
Curr Drug Deliv; 2021; 18(5):555-569. PubMed ID: 32842940
[TBL] [Abstract][Full Text] [Related]
18. Niosomal formulation for antibacterial applications.
Mehrarya M; Gharehchelou B; Haghighi Poodeh S; Jamshidifar E; Karimifard S; Farasati Far B; Akbarzadeh I; Seifalian A
J Drug Target; 2022 Jun; 30(5):476-493. PubMed ID: 35060818
[TBL] [Abstract][Full Text] [Related]
19. Recent Developments of Nanostructures for the Ocular Delivery of Natural Compounds.
Razavi MS; Ebrahimnejad P; Fatahi Y; D'Emanuele A; Dinarvand R
Front Chem; 2022; 10():850757. PubMed ID: 35494641
[TBL] [Abstract][Full Text] [Related]
20. Overview of Recent Advances in Nano-Based Ocular Drug Delivery.
Liu LC; Chen YH; Lu DW
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
